Formuepleje A S Lowers Position in Xylem Inc. $XYL

Formuepleje A S lessened its holdings in Xylem Inc. (NYSE:XYL) by 64.2% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 29,058 shares of the industrial products company’s stock after selling 52,126 shares during the period. Formuepleje A S’s holdings in Xylem were worth $3,435,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of XYL. HighTower Advisors LLC boosted its stake in Xylem by 1.6% in the second quarter. HighTower Advisors LLC now owns 87,234 shares of the industrial products company’s stock valued at $10,312,000 after acquiring an additional 1,356 shares in the last quarter. Groupe la Francaise increased its position in shares of Xylem by 21.1% during the second quarter. Groupe la Francaise now owns 94,672 shares of the industrial products company’s stock worth $11,195,000 after purchasing an additional 16,495 shares in the last quarter. Vancity Investment Management Ltd lifted its holdings in shares of Xylem by 13.3% during the 2nd quarter. Vancity Investment Management Ltd now owns 3,371 shares of the industrial products company’s stock valued at $398,000 after purchasing an additional 397 shares during the last quarter. California State Teachers Retirement System lifted its holdings in shares of Xylem by 11,093.8% during the 2nd quarter. California State Teachers Retirement System now owns 44,361,731 shares of the industrial products company’s stock valued at $5,244,000,000 after purchasing an additional 43,965,426 shares during the last quarter. Finally, Washington Trust Advisors Inc. boosted its position in shares of Xylem by 1.6% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70,141 shares of the industrial products company’s stock worth $8,291,000 after purchasing an additional 1,080 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Trading Up 0.2%

Xylem stock opened at $105.91 on Monday. The stock has a 50-day moving average price of $117.60 and a 200 day moving average price of $118.01. The company has a market capitalization of $24.73 billion, a price-to-earnings ratio of 25.22, a price-to-earnings-growth ratio of 1.70 and a beta of 1.00. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The company had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. During the same quarter in the prior year, the company earned $1.26 EPS. Xylem’s quarterly revenue was up 1.5% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Sell-side analysts anticipate that Xylem Inc. will post 5.66 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Stockholders of record on Thursday, August 27th will be issued a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, August 27th. Xylem’s dividend payout ratio is 40.95%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on XYL shares. Barclays boosted their price target on Xylem from $154.00 to $159.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. Citigroup reaffirmed a “buy” rating on shares of Xylem in a research report on Wednesday, July 29th. Jefferies Financial Group lifted their target price on shares of Xylem from $145.00 to $150.00 and gave the stock a “buy” rating in a research note on Monday, August 24th. Stifel Nicolaus boosted their target price on shares of Xylem from $157.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Finally, Royal Bank Of Canada upped their price target on shares of Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. Nine research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $155.00.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.